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INTRODUCTION
In underdeveloped countries, liver cirrhosis is a major 
cause of  morbidity and mortality owing to unawareness 
of  the patients, inadequate facilities and financial 
implications associated with the disease. In western 
world chronic alcohol consumption account for majority 
of  the cases but in our part of  the world infections by 
hepatotropic viruses (Hepatitis B & C) are most likely 
responsible. Liver cirrhosis follows an indolent course 
and eventually patients succumb to the complications of  
liver decompensation characterized by variceal bleeding 
from portal hypertension, ascites, hepatorenal syndrome, 
hepatic encephalopathy and spontaneous bacterial 
peritonitis.1 Esophageal varices are generally the most 
common clinical manifestation of  portal hypertension and 
ruptured esophageal varices are a dreaded complication of  
portal hypertension, accounting for approximately 3200 
deaths annually attributed to cirrhosis.2 Varices usually 
form when hepatic vein pressure gradient (determinant 
of  portal pressure) exceeds 10 mmHg and bleeds when 
it exceeds 12 mmHg. In cirrhosis, there is compression 
of  hepatic veins by regenerating nodules along with 
collagen deposition in sinusoids and venules, factors 
responsible for increased intrahepatic resistance. The 
increase in blood flow is incompletely understood but is 
Non-invasive parameters for the detection of variceal 
bleed in patients of liver cirrhosis, an experience of a 
tertiary care hospital in Pakistan
Anam Umar1, Fakhar Ali Qazi1, Rukhsana Abdul Sattar1, Beena Umar2
1Department of Medicine, Jinnah Postgraduate Medical Centre, 2Department of Histopathology and Microbiology, Aga Khan University 
Hospital, Karachi, Pakistan
ORIGINAL ARTICLE ASIAN JOURNAL OF MEDICAL SCIENCES
Address for Correspondence: 
Anam Umar, Department of Medicine, Ward 5, Jinnah Postgraduate Medical Centre, Karachi. 
E-mail: anam_umar@hotmail.com; Moblie: +923478300237 © Copyright AJMS
Submitted: 17‑01‑2014 Revised: 12‑05‑2014 Published: 30‑08‑2014
A B S T R A C T
Access this article online
Website: 
http://nepjol.info/index.php/AJMS
Objective: Cirrhotic patients commonly undergo screening endoscopy for the existence 
of esophageal varices. The use of this invasive procedure which is expensive, poorly 
tolerable and generally not acceptable for the patients is increasing due to increasing 
number of patients with chronic liver disease and their enriched survival. In this study, our 
aim is to identify clinical, biochemical, and ultrasonography parameters which might non-
invasively predict the presence of esophageal varices and risk of bleeding in patients with 
liver cirrhosis. Material and Methods: Total 150 Patientsof chronic liver disease admitted 
in ward-5, JPMC(Sep 2011-Feb 2012) with a complaint of hematemesis or melena were 
included in the study. Platelet counts of 75,000 to 150,000/µL was defined as grade 1 
thrombocytopenia, 50,000 to <75,000/µL as grade II, 25,000 to <50,000/µL as grade III 
and below 25,000/µL as grade IV. The normal range for the INR is 0.8–1.2. Portal vein 
size of 1.2 cm or above was taken as dilated. Spleen of >13 cm was considered as 
enlarged in our study. Results: Out of 72 patients of variceal bleed 69 (46%) were males 
and 81(54%) were females. Thrombocytopenia was present in 64 (88%) patients with 
mean platelet count of 85.86/µL (±69.79). Deranged coagulation profile was present in 
56 (77%) cases with mean INR of 1.63 (±0.5). Portal vein diameter (PVD) of >1.2 cm 
was found in 46(63.8%) of patients with mean PVD of 1.22(±0.3023) and splenic size of 
>13 cm was reported in 54 (75%) cases with mean splenic diameter of 14.5 cm (±2.39). 
Conclusion: Thrombocytopenia, deranged coagulation profile, large splenic size, and dilated 
portal vein strongly predict the risk of variceal bleeding.
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probably due to circulating vasodilators and alterations 
in fluid and electrolyte balance. All these interactions 
result in the development of  increase portal pressure 
and Porto‑systemic collateral formation. These collaterals 
decompress the portal circulation by shunting the blood 
to the heart via the systemic venous circulation and the 
major sites of  these collaterals are the esophagus, rectum, 
umbilicus and retro peritoneum.3,4,5 Gastro esophageal 
varices are present in approximately 50% of  patients with 
cirrhosis with a lifetime incidence of  90%. Their presence 
also correlate with the severity of  disease, being more 
common in Child Pugh Class C patients as compared 
to Child Pugh Class A patients (85% versus 40%)6,7,8 
(Table 1). Variceal hemorrhage is a medical emergency. 
Approximately one third of  patients with esophageal 
varices experience variceal bleeding with a mortality rate 
of  up to 20%. After an initial episode, there is 70% chance 
of  re‑bleeding within a year with a mortality rate of  up to 
33% in the absence of  any treatment9 Due to this reason 
a screening endoscopy is indicated in all patients with 
newly diagnosed cirrhosis to minimize the complications 
and also to reduce mortality associated with acute variceal 
bleed.2 It has also been suggested to repeat endoscopy 
at every 2‑3 years interval in patients without varices 
and at 1‑2 years interval in patients with small varices to 
evaluate for progression10 Current treatment modalities 
have substantially reduced the rate of  first and recurrent 
bleeding and has also decreased the mortality associated 
with acute variceal bleed.11 However screening all patients 
with endoscopy will significantly increase the cost and 
has also variable patient compliance. A number of  other 
factors such as platelet count, coagulation profile, splenic 
size and portal vein diameter also correlate with the risk 
of  variceal bleed and can be assessed by less invasive 
and routine tests carried out on the patients of  cirrhosis. 
Due to cost effectiveness and to limit the number of  
endoscopic procedures, these parameters become more 
significant and carry paramount importance in making it 
possible for endoscopy to be carried out only in selected 
group of  patients thus to avoid un‑necessary intervention 
and at the same time not to miss patients at risk of  
bleeding. Therefore, the present study has been carried 
out to identify clinical, biochemical and ultrasonographic 
parameters which might non‑invasively predict the 
existence and the risk of  variceal bleed.
MATERIAL AND METHOD
A total of  150 patients with chronic liver disease, 
admitted to the department of  medicine, ward 5, Jinnah 
Postgraduate Medical Centre from September 2011 to 
February 2012 were included in this study. All patients 
were categorized into two groups according to the 
presence or absence of  upper GI bleed in the form of  
hematemesis or melena. Diagnosis of  liver cirrhosis was 
based on combination of  clinical signs & symptoms, 
laboratory findings (deranged coagulation profile, reversal 
of  albumin/globulin ratio) and Ultrasonographic findings 
(size and echogenicity of  the liver). Patients suffering from 
acute liver failure, non‑cirrhotic portal hypertension, and 
tropical splenomegaly were excluded from the study.
A structured proforma was used for data collection. 
Detailed history was obtained and patients were examined 
with special attention to anemia, jaundice, palmarerythema, 
spider nevi, gynaecomastia, edema, splenomegaly 
and ascites. Relevant hematological, biochemical and 
radiological investigations were ordered including complete 
blood count, urea, creatinine and electrolytes, liver function 
tests, coagulation profile, serum proteins, serum albumin 
and globulin ratio, HBsAg, Anti HCV Antibody, urine 
D/R, ascetic fluid D/R, serum ammonia, chest X-Ray, 
ultrasound abdomen and upper GI endoscopy (as part of  
routine workup) (Table 2).
Upper gastrointestinal bleed was defined on the basis of  
hematemesis or melena. Thrombocytopenia as platelet 
count of  <150,000/mm3, deranged coagulation profile 
as INR of  >1.2, splenomegaly as splenic size of  >13 cm 
anddilated portal vein diameter of>1.2 cm on ultrasound. 
Platelet counts of  75,000 to 150,000/µL was defined as 
grade I thrombocytopenia, 50,000 to 75,000/µL as grade II, 
25,000 to 50,000/µL as grade III, and below 25,000/µL as 
grade IV thrombocytopenia.
Statistical analysis was done using SPSS version 19 and 
the results were obtained in the terms of  frequencies and 
percentages for descriptive analysis. Chi‑Square and student 
t tests were used to analyze the numerical data and p value 
of  <0.05 was set to be statistically significant.
RESULTS
Age & Gender
There were eighty one (n=81, 54%) females and sixty 
nine (n=69, 46%) males. The range of  patient’s age was 
14-83 yrs. 58% (n=87) of  the patients in our study belong to 
the age group of  40 – 60 years with mean age of  50.9 years 
and Standard deviation of  ±13.171 (Figures 1 & 2).
Table 1: Child pugh classification
1 2 3
Bilirubin (mg/dl) <2 2 ‑ 3 >3
Serum albumin (g/dl) >3.5 2.8 ‑ 3.5 <2.8
Grade of encephalopathy None Mild Moderate to severe
Grade of ascites None Mild Moderate to severe
INR <1.2 1.2 ‑ 1.7 >1.7
Child A: 5‑6, Child B: 7‑9, Child C: 10‑15
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Frequency of viral hepatitis
The most common cause of  chronic liver disease was found 
to be HCV in our patients. Frequency of  viral hepatitis as 
a cause of  chronic liver disease is mentioned in Figure 3.
Frequency of upper GI bleed
72 patients in our study presented with GI Bleed that makes 
48% of  total cases while 78 patients (52%) patients had no 
history of  upper GI bleed. Out of  72 patients, 22 (15%) 
patients presented with hematemesis, 12 (8%) had melena 
and 38 (25%) patients presented with both hematemesis 
and melena (Figure 4).
NON-INVASIVE PARAMETERS FOR ESOPHAGEAL 
VARICES
Thrombocytopenia
Thrombocytopenia was present in 64 (88%) patients, 
with mean platelet count of  85.86/µL (±69.79) in 
? ? ?? ??
??
? ? ?? ? ?? ?? ?? ? ? ????? ?????????????????????????????????????????? ????????????????
Figure 1: Age prevalence
?? ???? ?????? ??????
?????? ???????
Figure 2: Gender prevalence
Table 2: Laboratory parameters of all patients with chronic liver disease
Without bleed With bleed p-value
Mean Std. Deviation Mean Std. Deviation
Hemoglobin (mg/dl) 8.429 2.2389 8.184 2.0675 0.492
Mean cell volume (fl) 88.421 14.1289 91.584 10.0995 0.142
TLC (x109/L) 8.790 6.1854 8.453 5.7380 0.739
Platelets/mm3 113.96 67.188 86.10 69.645 0.012*
Random blood sugar (mg/dl) 137.58 84.530 137.64 68.215 0.997
Urea (mg/dl) 57.09 47.601 52.11 35.582 0.492
Creatinine (mg/dl) 1.4016 1.04940 1.1420 0.61934 0.084
Serum sodium (meq/l) 132.472 7.1617 133.277 9.3108 0.578
Serum potassium (meq/l) 4.2748 3.40198 3.9015 0.75980 0.400
Serum chloride (meq/l) 102.746 8.4363 103.127 6.2709 0.792
Total bilirubin (mg/dl) 4.2211 5.38458 3.3395 3.87788 0.300
Direct bilirubin (mg/dl) 1.9992 3.25431 1.6781 2.40724 0.540
Indirect bilirubin (mg/dl) 2.1063 2.44664 1.6953 1.72525 0.300
ALT (u/l) 44.81 53.126 51.90 39.677 0.428
AST (u/l) 85.15 64.431 99.00 109.509 0.439
ALP (u/l) 372.20 285.201 296.13 226.103 0.118
GGT (u/l) 58.13 74.675 47.33 35.865 0.358
Total proteins (mg/dl) 8.141 7.1363 8.202 9.6373 0.970
Serum albumin (mg/dl) 3.125 0.5835 3.623 4.1489 0.376
Globulin (mg/dl) 4.037 0.9202 3.677 0.8849 0.050
A/G ratio 0.810 0.1880 0.845 0.2007 0.390
INR 1.3731 0.45532 1.6385 0.50358 0.001*
Serum ammonia (μg/dl) 164.00 74.740 253.33 98.845 0.016*
Liver span (cm) 11.562 2.1332 12.029 3.3295 0.584
Portal vein diameter (cm) 1.092 0.2583 1.224 0.3023 0.007*
Spleen size (cm) 13.082 2.3503 14.565 2.3994 0.000*
Splenic vein diameter (cm) 1.167 0.2066 0.700 0.2828 0.041*
* Significant P-value
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patients with upper GI bleed. While 63 patients with 
no history of  upper GI bleed had thrombocytopenia 
with mean platelet count of  113.96 (p‑value 0.014). 
Statistically significant relationship was found between 
the severity of  thrombocytopenia and risk of  bleed 
in CLD patients (Figure 5) (Pearson’s Chi Square: 
p value = 0.009).
Coagulation profile
Deranged coagulation profile was present in 56 (77%) 
cases with GI Bleed, with mean INR of  1.63 (±0.5) in 
contrast to only 39 patients (50%) without upper GI Bleed 
had deranged coagulation profile with a mean INR of  
1.37 (±0.45)(p value = 0.001). Level of  significance was 
determined by application of  Pearson chi square (p‑value 
0.001) (Figure 6).
Portal vein diameter
Portal vein diameter of  >1.2 cm was found in 46 (63.8%) 
patients who presented with GI Bleed with mean PVD 
of  1.22 cm (±0.3023), (p value = 0.005) while 35 (44.8%) 
patients without bleed had dilated portal vein on ultrasound 
with mean PVD of  1.092 cm (±0.02). Level of  significance 
was determined by application of  Pearson chi square 
(p‑value 0.022) (Figure 7).
Splenic size
A splenic size of  >13 cm was found in 54 (75%) cases 
having mean splenic diameter of  14.5 cm(±2.39)(p value 
<0.001). On the other hand, 35 (44%) patients without GI 
Bleed had splenomegaly with mean splenic diameter of  
13.08 cm (±2.35). Level of  significance was determined 
by application of  Pearson chi square (p‑value 0.000) 
(Figure 8).
DISCUSSION
Acute Upper GI hemorrhage is a medical emergency with 
high morbidity and mortality, numerous hospital admissions 
and a high burden on health care providers.12,13 Esophageal 
varices are the major cause of  upper GI hemorrhage in our 
setting as compared to peptic ulcer in western population. 
Despite significant improvements in early diagnosis and 
advancements made in the treatment modalities, the 
mortality rate of  first variceal hemorrhage is still 20%. 
Numerous studies have demonstrated the significance 
of  pharmacologic therapy for primary prevention of  
????????????????? ???????????? ??????????? ?????? ????
Figure 4: Frequency of upper GI bleed?? ?? ?? ? ?? ?? ?? ?? ???????? ??????? ??????? ??????? ???????
?????? ???????
Figure 5: Grades of thrombocytopenia vs GI bleed (statistically significant difference was found between the groups by applying Pearson Chi 
Square (p-value 0.005))
???? ???????????????????? ??? ??? ????????????????
Figure 3: Frequency of viral hepatitis
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Figure  6: Coagulation profile vs GI bleed?? ???? ??????????????????? ???????????????????
???????????????? ?????????????
Figure 7: Portal vein size vs GI bleed?? ???? ??????????????? ??????????????????????????????? ?????????????
Figure 8: Splenomegaly vs GI bleed
variceal bleeding, emphasizing the importance of  screening 
endoscopy in all newly diagnosed cirrhotic patients for 
the presence of  varices.9,14 Therefore, there is a particular 
need for the identification of  noninvasive parameters that 
strongly predict the presence of  esophageal varices as that 
might decreases the medical, public and economic burden 
of  the disease.
Our Study demonstrated that thrombocytopenia, deranged 
coagulation profile, presence of  portal hypertension with 
splenomegaly and portal vein diameter are strong predictors 
of  developing variceal bleed presenting clinically as upper 
GI hemorrhage.
Earlier, the pathophysiology of  thrombocytopenia in liver 
disease was linked to the presence of  hyperspleenism, 
but now it has been discovered that thrombopoetin 
production is dependent on functioning liver cell mass 
and is responsible for reduced thrombopoiesis and 
consequently peripheral thrombocytopenia in patients of  
advanced liver disease.15,16 Prolonged PT is also related 
to the severity of  liver diseases and is also a simple, 
inexpensive and accurate marker of  liver impairment and 
a predictor of  upper gastrointestinal bleeding in chronic 
liver disease.17
Splenomegaly and portal vein diameter are also reliable 
predictors of  variceal hemorrhage, in a study carried 
out by Mandal et al18 it has been shown that grading of  
esophageal varices also correlate with splenic size and 
portal vein diameter. In their study average portal vein 
diameter and splenic size in high grade varices were 14.43 
± 0.86 mm and 15.36 ± 2.14 cm. Sharma and Agarwal in 
their study had noted that clinically palpable spleen was 
associated with high grade varices however they did not 
measure the splenic size radiologically.19 The measurement 
of  the splenic diameter using ultrasonography is easily 
obtainable, reproducible, non‑invasive and is routinely 
performed on patients with cirrhosis. In another study 
carried it was demonstrated that the platelet count/
spleen diameter ratio is also useful in the discrimination 
of  large versus small varices and in their study a platelet 
spleen diameter ratio of  less than 909 was statistically 
significant in predicting large varices.20 Farooqi et al21 also 
found out that platelet count of  < 65 x 103/µL, serum 
albumin <2.2 g/dl and portal vein diameter of  >13 mm 
are independent and significant predictors of  esophageal 
varices on endoscopy.
Though, upper GI endoscopy remains the gold standard 
for the diagnosis of  esophageal varices in cirrhotic patients, 
from the present study and a number of  other studies it 
has been found that certain non‑endoscopic parameters 
such as thrombocytopenia (<75,000/mm3), coagulation 
profile (PT >1.3), spleen size (>13 cm), and portal vein 
diameter (>1.2 cm) are significant and reliable predictors 
of  esophageal varices on endoscopy, therefore screening 
endoscopy could be safely limited to the group of  cirrhotic 
patients with no history of  upper GI bleed but in the 
presence of  above deranged parameters.
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